Abstract
Proton Pump Inhibitors (PPI) are consumed by millions of people around the world, either by prescription or self-medication, some medications of this group are Over-the-counter (OTC) medicines. PPIs have been associated with hypergastrinemia, rebound acid hypersecretion, malabsorption, osteoporosis and infections. This is an updated review of clinical pharmacology aspects of IPBS, with emphasis on safety aspects.
Cite
CITATION STYLE
Oscanoa Espinoza, T. J. (2011, January). Seguridad de los inhibidores de la bomba de protones. Revista de Gastroenterología Del Perú : Órgano Oficial de La Sociedad de Gastroenterología Del Perú. https://doi.org/10.4321/s1130-01082011000200011
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.